Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Molly E Johnson

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Msphere|January 24, 2018
Identification of Head and Neck Cancer Subtypes Based on Human Papillomavirus Presence and E2F-Regulated Gene ExpressionMolly E Johnson, Paul G Cantalupo, James M Pipas
Idcases|November 1, 2017
Disseminated histoplasmosis in a patient with common variable immunodeficiency: A coincidence or the result of T cell defects?Molly E Johnson, Christian Rojas-Moreno, William Salzer, et al.
Molecular Therapy. Methods & Clinical Development|May 26, 2022
Quantitative single-cell transcriptome-based ranking of engineered AAVs in human retinal explantsZhouhuan Xi, Bilge E Öztürk, Molly E Johnson, et al.
Elife|October 19, 2021
scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolutionBilge E Öztürk, Molly E Johnson, Michael Kleyman, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Structural dynamics insights into principles underlying the fitness of new broadly potent AAVsMolly E Johnson, Bilge E Ozturk, Thomas H Tugwell, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Msphere|January 24, 2018
Identification of Head and Neck Cancer Subtypes Based on Human Papillomavirus Presence and E2F-Regulated Gene ExpressionMolly E Johnson, Paul G Cantalupo, James M Pipas
Idcases|November 1, 2017
Disseminated histoplasmosis in a patient with common variable immunodeficiency: A coincidence or the result of T cell defects?Molly E Johnson, Christian Rojas-Moreno, William Salzer, et al.
Molecular Therapy. Methods & Clinical Development|May 26, 2022
Quantitative single-cell transcriptome-based ranking of engineered AAVs in human retinal explantsZhouhuan Xi, Bilge E Öztürk, Molly E Johnson, et al.
Elife|October 19, 2021
scAAVengr, a transcriptome-based pipeline for quantitative ranking of engineered AAVs with single-cell resolutionBilge E Öztürk, Molly E Johnson, Michael Kleyman, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Structural dynamics insights into principles underlying the fitness of new broadly potent AAVsMolly E Johnson, Bilge E Ozturk, Thomas H Tugwell, et al.
Pageof 1